| 000 | 01357 a2200385 4500 | ||
|---|---|---|---|
| 005 | 20250510205307.0 | ||
| 264 | 0 | _c19790328 | |
| 008 | 197903s 0 0 eng d | ||
| 022 | _a0020-8272 | ||
| 024 | 7 |
_a10.1159/000468344 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aPöldinger, W | |
| 245 | 0 | 0 |
_aTherapy of extrapyramidal side effects, with particular reference to persistent dyskinesia and lithium tremor. _h[electronic resource] |
| 260 |
_bInternational pharmacopsychiatry _c1978 |
||
| 300 |
_a230-3 p. _bdigital |
||
| 500 | _aPublication Type: Clinical Trial; Journal Article | ||
| 650 | 0 | 4 | _aAdolescent |
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 |
_aAmantadine _xtherapeutic use |
| 650 | 0 | 4 |
_aAntipsychotic Agents _xadverse effects |
| 650 | 0 | 4 |
_aBasal Ganglia Diseases _xchemically induced |
| 650 | 0 | 4 |
_aBromocriptine _xtherapeutic use |
| 650 | 0 | 4 | _aChronic Disease |
| 650 | 0 | 4 | _aClinical Trials as Topic |
| 650 | 0 | 4 |
_aDyskinesia, Drug-Induced _xdrug therapy |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aLithium _xadverse effects |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 |
_aOxprenolol _xtherapeutic use |
| 650 | 0 | 4 |
_aTremor _xchemically induced |
| 773 | 0 |
_tInternational pharmacopsychiatry _gvol. 13 _gno. 4 _gp. 230-3 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1159/000468344 _zAvailable from publisher's website |
| 999 |
_c31163 _d31163 |
||